Literature DB >> 29371686

Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease.

Alexander Coltoff1, Guido Lancman1, Sara Kim2, Amir Steinberg3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29371686     DOI： 10.1038/s41409-018-0094-8

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 2.  Challenges and opportunities targeting mechanisms of epithelial injury and recovery in acute intestinal graft-versus-host disease.

Authors:  Suze A Jansen; Edward E S Nieuwenhuis; Alan M Hanash; Caroline A Lindemans
Journal:  Mucosal Immunol       Date:  2022-06-02       Impact factor: 8.701

Review 3.  The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease.

Authors:  Jarosław Biliński; Marcin Jasiński; Grzegorz W Basak
Journal:  Biomedicines       Date:  2022-04-01

Review 4.  Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity.

Authors:  Qingxiao Song; Ubaydah Nasri; Ryotaro Nakamura; Paul J Martin; Defu Zeng
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

Review 5.  Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease.

Authors:  Aditya Rayasam; William R Drobyski
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 8.786

6.  Human resident memory T cells exit the skin and mediate systemic Th2-driven inflammation.

Authors:  Johanna Strobl; Laura Marie Gail; Lisa Kleissl; Ram Vinay Pandey; Valerie Smejkal; Julian Huber; Viktoria Puxkandl; Luisa Unterluggauer; Ruth Dingelmaier-Hovorka; Denise Atzmüller; Thomas Krausgruber; Christoph Bock; Philipp Wohlfarth; Werner Rabitsch; Georg Stary
Journal:  J Exp Med       Date:  2021-10-13       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.